Dermata Therapeutics Inc Warrants (13/08/2026) (DRMAW) Stock Price, Quote, News & History

Key Statistics

Open

Volume / Avg.

0 / 16.82K

Day Range

- - -

52 Wk Range

0.00 - 0.03

Market Cap

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

Recent Dermata Therapeutics Inc News

Why Dermata Therapeutics Stock Took Off After-Hours

Dermata Therapeutics, Inc.

Ryan Gustafson

PRO
Dermata Therapeutics Secures Australian Patent Acceptance For Bioneedle System In Dermal Fillers

- This would be Dermata's first patent, if issued, covering the use of its Bioneedle Delivery System ("BDS") with dermal fillers -- The Company also has allowed and issued patents in the US, Australia, and Japan covering

Benzinga Newsdesk

PRO
Dermata Therapeutics Announces Private Placement Up To $12.4M

Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a science-driven leader in dermatologic solutions, today announced that it has entered into definitive agreements for the issuance and

Benzinga Newsdesk

PRO
Dermata Therapeutics Announces Australian Patent Office Accept Patent Application For Spongilla Technology Combination As Method For Treating Acne

- This acceptance follow's Dermata's U.S. issued patent covering its Spongilla technology combination as a method to topically treat acne -- Dermata expects to launch a new once-weekly, Over-the-Counter (OTC)

Benzinga Newsdesk

PRO
Dermata Therapeutics Announces Strategic Pivot To Prioritize Development And Distribution Of OTC Pharmaceutical Dermatology Focused Products

Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata" or the "Company"), a science-driven leader in dermatologic solutions, today announced a bold strategic pivot to prioritize the development and

Benzinga Newsdesk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Key Statistics

Open

Volume / Avg.

0 / 16.82K

Day Range

- - -

52 Wk Range

0.00 - 0.03

Market Cap

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

DRMAW

ABBV

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

DRMAW

ABBV

FAQ

How do I buy Dermata Therapeutics Inc Warrants (13/08/2026) (DRMAW) stock?

You can purchase shares of Dermata Therapeutics Inc Warrants (13/08/2026) (NASDAQ:DRMAW) through any online brokerage.

View our list of the best stock brokerages

Who are Dermata Therapeutics Inc Warrants (13/08/2026) (DRMAW) competitors?

Other companies in Dermata Therapeutics Inc Warrants (13/08/2026)’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

What is the forecast, or price target, for Dermata Therapeutics Inc Warrants (13/08/2026) (DRMAW) stock?

There is no analysis for Dermata Therapeutics Inc Warrants (13/08/2026) to provide a consensus price target.

What is the current price for Dermata Therapeutics Inc Warrants (13/08/2026) (DRMAW)?

The stock price for Dermata Therapeutics Inc Warrants (13/08/2026) (NASDAQ: DRMAW) is $0.002 last updated August 14, 2026 at 9:29 AM EDT.

Does Dermata Therapeutics Inc Warrants (13/08/2026) (DRMAW) pay a dividend?

There are no upcoming dividends for Dermata Therapeutics Inc Warrants (13/08/2026).

When is Dermata Therapeutics Inc Warrants (13/08/2026) (NASDAQ:DRMAW) reporting earnings?

Dermata Therapeutics Inc Warrants (13/08/2026) does not have any upcoming earnings scheduled.

Is Dermata Therapeutics Inc Warrants (13/08/2026) (DRMAW) going to split?

There is no upcoming split for Dermata Therapeutics Inc Warrants (13/08/2026).

What sector and industry does Dermata Therapeutics Inc Warrants (13/08/2026) (DRMAW) operate in?

Dermata Therapeutics Inc Warrants (13/08/2026) is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Benzinga

Benzinga